Mentari Therapeutics: Funding, Investors & Team (Nov 2026)
Mentari Therapeutics is a biotechnology company developing therapies for the prevention of migraine.
Mentari Therapeutics has raised $200M across 1 funding round on record, the most recent a Private Equity of $200M announced in Jul 2026.
That round is above the $65M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mentari Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Mentari Therapeutics Funding Rounds
Mentari Therapeutics Investors
11 investors are recorded in total; the 5 named above are those the record identifies.
Mentari Therapeutics Funding Compared to Other Biotechnology Startups
Mentari Therapeutics' latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mentari Therapeutics in Biotechnology and Waltham
Companies Similar to Mentari Therapeutics
Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover &…
NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration…
Boulevard Bio is a biotechnology company founded by Deerfield Management that develops novel therapies for…
Syngenis Labs is committed to helping businesses and research organizations with their diagnostic and…
Zipline designs, manufactures, and operates drones to deliver vital medical products.
Numica provides accounting and tax services for companies and individuals.
Firmly.ai is agentic commerce platform enabling seamless product discovery and checkout across AI and digital…
Arena applies predictive analytics and machine learning to talent acquisition challenges.
Synopsis is an AI driven tech company that offers data integration services.
Siggy is an AI-powered mental healthcare platform that combines digital therapy support, psychiatric…
Nyquis is an AI-powered grid protection platform that detects electrical faults in real time to prevent…
Sanaren builds human-centered technologies and compassionate digital solutions designed to support active…
Mentari Therapeutics Funding FAQs
What does Mentari Therapeutics do?
Mentari Therapeutics is a biotechnology company developing therapies for the prevention of migraine.
How much funding has Mentari Therapeutics raised?
Mentari Therapeutics has raised $200M across 1 round on record. The most recent is a Private Equity of $200M announced in Jul 2026.
When did Mentari Therapeutics last raise funding?
Mentari Therapeutics' most recent funding round on record is a Private Equity of $200M, announced in Jul 2026.
Who has invested in Mentari Therapeutics?
Investors on record for Mentari Therapeutics include Janus Henderson Investors, RTW Investments, Commodore Capital, Vivo Capital, Fairmount Funds Management. FundedIQ records 11 investors in total.
Where is Mentari Therapeutics headquartered?
Mentari Therapeutics is based in Waltham, United States.
How does Mentari Therapeutics' funding compare to other Biotechnology startups?
Mentari Therapeutics' latest round of $200M is above the $65M median round size for Biotechnology companies on FundedIQ across 6 tracked companies over the last two years.
About FundedIQ's Mentari Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mentari Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.